About
Abbvie Inc. is a global, research-oriented company specializing in the field of biotechnology and pharmaceuticals. It was founded in 2013 as a spin-off from Abbott Laboratories. Abbvie's headquarters are in North Chicago, Illinois, and it employs over 47,000 people in more than 75 countries worldwide. The company focuses on researching, developing, and marketing high-quality therapies for the treatment of serious and life-threatening diseases. Abbvie has several business divisions, including immunology, oncology, neurology, and virology, and is known for its investments in research and development. Its key products include adalimumab (sold under the brand name Humira) for autoimmune diseases and Imbruvica for chronic lymphocytic leukemia. Abbvie is recognized as a leading company in the biotechnology and pharmaceutical industry due to its focus on innovative therapies and medicines.
Annual results
Reported figures, USD · revenue up 8.6% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 61.2B | 4.2B | 6.9% | — |
| 2024 | 56.3B | 4.3B | 7.6% | 17.8B |
| 2023 | 54.3B | 4.9B | 9.0% | 22.1B |
| 2022 | 58.1B | 11.8B | 20.4% | 24.2B |
| 2021 | 56.2B | 11.5B | 20.5% | 22.0B |
Dividends per share
Recent SEC filings
- Regulation FD disclosure · Financial statements and exhibits8-K · 2026-09-03
- Other material event · Financial statements and exhibits8-K · 2026-08-18
- Other material event · Financial statements and exhibits8-K · 2026-08-05
- Quarterly report10-Q · 2026-08-03
- Results of operations · Financial statements and exhibits8-K · 2026-07-31
- Results of operations · Financial statements and exhibits8-K · 2026-07-06
ABBV in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for AbbVie Inc are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Filings from SEC EDGAR. Reported figures, not investment advice.